|
CDK13 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.57729999950007E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.72410000001777E-07 |
| Normal-vs-Stage2 |
1.125930E-02 |
| Normal-vs-Stage3 |
6.22909999999921E-05 |
| Normal-vs-Stage4 |
2.036800E-03 |
| Stage1-vs-Stage2 |
8.229800E-01 |
| Stage1-vs-Stage3 |
7.033400E-01 |
| Stage1-vs-Stage4 |
3.267600E-01 |
| Stage2-vs-Stage3 |
9.954600E-01 |
| Stage2-vs-Stage4 |
6.801200E-01 |
| Stage3-vs-Stage4 |
5.522200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.66960000047567E-07 |
| Normal-vs-AfricanAmerican |
4.381600E-02 |
| Normal-vs-Asian |
1.72030000000767E-06 |
| Caucasian-vs-AfricanAmerican |
1.140570E-01 |
| Caucasian-vs-Asian |
3.645900E-02 |
| AfricanAmerican-vs-Asian |
2.575700E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.85176999999426E-05 |
| Normal-vs-Female |
1.57009999446345E-08 |
| Male-vs-Female |
7.025700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.710400E-02 |
| Normal-vs-Age(41-60Yrs) |
2.01310000003119E-07 |
| Normal-vs-Age(61-80Yrs) |
4.01039999997632E-06 |
| Normal-vs-Age(81-100Yrs) |
3.060400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.508600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.249000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.897400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.019000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.721250E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.914800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.613000E-04 |
| Normal-vs-Grade 2 |
1.8136000035085E-08 |
| Normal-vs-Grade 3 |
1.579590E-04 |
| Normal-vs-Grade 4 |
1.080130E-02 |
| Grade 1-vs-Grade 2 |
7.866200E-01 |
| Grade 1-vs-Grade 3 |
2.104400E-01 |
| Grade 1-vs-Grade 4 |
2.352400E-01 |
| Grade 2-vs-Grade 3 |
1.847740E-02 |
| Grade 2-vs-Grade 4 |
7.387500E-02 |
| Grade 3-vs-Grade 4 |
8.136000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.93360005363542E-09 |
| Normal-vs-ccB subtype |
2.01749999995116E-06 |
| ccA subtype-vs-ccB subtype |
4.497600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.68620000079645E-08 |
| Normal-vs-N1 |
1.795650E-01 |
| N0-vs-N1 |
6.208600E-01 |
|
|
